Lyme Vaccine Mystery

Lyme Vaccine Mystery

What happened to the Lyme disease vaccine? 

From the perspective of the original physician researcher Dr. Vijay Sikand, this short clip shares the fascinating history of how the Lyme disease vaccine worked and why it was ultimately abandoned following unproven lawsuits regarding side effects.  The vaccine manufacturer now known as GSK pulled their vaccine Lymerix from the market in 2002.  Subsequently these conditions caused the vaccine manufacturer now known as Sanofi to withdraw their license application for their own Lyme vaccine candidate, Imulyme.  

The result; there hasn’t been a Lyme vaccine available now for decades. Fortunately, there is Lyme disease prevention hope on the horizon. Pfizer & Valneva are currently developing a new Lyme vaccine candidate VALOR, VLA15 that is close to submission for FDA review. More good news, due to the relationship Physician’s Buying Group PBG / PracticeWell currently has with Pfizer & Valneva it is likely a vaccine discount for VALOR may be available to members when the time comes. Vaccine discounts are of the highest priority to the team at PracticeWell.Join PracticeWell for free today!